ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effect of mesenchymal-epithelial transition amplification on immune microenvironment and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer

Su, Shan; Lin, Anqi; Luo, Peng; Zou, Jianjun; Huang, Zhihao; Wang, Xiaojun; Zeng, Yunyun; Cen, Wenchang; Zhang, Xianlan; Huang, Huiyi; Hu, Jinxing*; Zhang, Jian*南方医科大学
Annals of Translational Medicine2021-9DOI: 10.21037/atm-21-4543
3被引9阅读
引用收藏
分享

摘要

Background: Immune checkpoint inhibitors (ICIs) have brought clinical benefits to patients with various histological types of lung cancer. Previous studies have shown an association between mesenchymal-epithelial transition (MET) and the immunotherapy response in non-small cell lung cancer (NSCLC) but there is a lack of clinical data on the correlation of MET amplification with the ICI response in NSCLC. @@@ Methods: Copy number alteration (CNA), somatic mutation, and clinical data from two immunotherapy cohorts (Rizvi et al. cohort and our local cohort) were collected and pooled to further investigate the key role of MET amplification in patients with NSCLC receiving ICIs. The correlations between MET amplification and tumor immunogenicity and antitumor immunity were further investigated in The Cancer Genome Atlas (TCGA)-NSCLC [lung adenocarcinoma (LUAD)/lung squamous cell carcinoma (LUSC)] data-set. @@@ Results: In the immunotherapy cohorts, MET amplification was associated with longer progression-free survival (PFS) times in patients receiving ICI treatment (P=0.039; HR=0.37; 95% CI: 0.18-0.73). In the TCGA-NSCLC data-set, MET amplification was associated with high MET mRNA and protein levels, tumor mutation burden (TMB), neoantigen load (NAL), immune-activated cell patterns, immune-related gene expression levels, and the number of gene alterations in the DNA damage response and repair (DDR) pathway. Gene set enrichment analysis (GSEA) results indicated significant up-regulation of the immune response-related pathways in the MET-amplification group. @@@ Conclusions: Our results suggest that MET amplification may be a novel predictive marker for immunotherapy efficacy in NSCLC.

学科与关键词

关键词
Mesenchymal-epithelial transition amplification (MET amplification)immunotherapyimmune microenvironmentimmune checkpoint inhibitors (ICIs)non-small cell lung cancer (NSCLC)
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Annals of Translational Medicine
发表日期
2021-09
卷期
第 9 卷, 第 18 期
页码
1475
DOI
10.21037/atm-21-4543
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82003304]; Guangzhou Science and Technology Program, China [202102080013]

作者

  • S

    Su, Shan (第一作者)

    guangzhou chest hosp

  • L

    Lin, Anqi

    southern med univ

查看全部 12 位作者收起作者
  • L

    Luo, Peng

    southern med univ

  • Z

    Zou, Jianjun

    guangzhou chest hosp

  • H

    Huang, Zhihao

    guangzhou chest hosp

  • W

    Wang, Xiaojun

    first peoples hosp chenzhou

  • Z

    Zeng, Yunyun

    guangzhou chest hosp

  • C

    Cen, Wenchang

    guangzhou chest hosp

  • Z

    Zhang, Xianlan

    guangzhou chest hosp

  • H

    Huang, Huiyi

    guangzhou chest hosp

  • H

    Hu, Jinxing (通讯)

    guangzhou chest hosp

  • Z

    Zhang, Jian (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417